SCHEMBL25010448

SCHEMBL25010448

CSc1oc(-c2ccc(C)cc2)nc1S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.77

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.77
KDM4E B2RXH2 2/20 0.77
HPGD P15428 2/20 0.77
MEN1 O00255 2/20 0.77
KMT2A Q03164 2/20 0.77
MAPK1 P28482 1/20 0.77
NPSR1 Q6W5P4 1/20 0.77
MAPT P10636 9/20 0.62
TP53 P04637 6/20 0.62
THRB P10828 1/20 0.61
TSHR P16473 3/20 0.61
HSD17B10 Q99714 2/20 0.61
HTT P42858 2/20 0.61
LMNA P02545 1/20 0.61
NPC1 O15118 1/20 0.56
TDP1 Q9NUW8 1/20 0.52
POLB P06746 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25011046 0.89 KDM4E (0.88) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL25009609 0.89 ALDH1A1 (0.79) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL25009355 0.88 KDM4E (0.90) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL25010436 0.88 KDM4E (0.90) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL25009171 0.87 MAPT (0.65) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL25009351 0.87 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL25009348 0.85 MAPT (0.67) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL25009353 0.84 MAPT (0.66) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL3022076 0.82 ALDH1A1 (0.81) ALDH1A1MEN1KMT2AMAPTTP53
SCHEMBL25010433 0.82 KDM4E (1.00) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY NFKBIA, IKBKB, NFKB2 ALDH1A1 4286/4885KDM4E 2556/4885HPGD 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.